Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Older

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
The Annals of Thoracic Surgery|April 1, 1989
Predonated autologous blood use in elective cardiac surgeryL W Britton, D T Eastlund, S W Dziuban, et al.
The Journal of Thoracic and Cardiovascular Surgery|April 1, 1981
Four-year follow-up on the Albany experience with intrapleural BCG in lung cancerM F McKneally, C Maver, L Lininger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 10, 2012
Mutation at positively selected positions in the binding site for HLA-C shows that KIR2DL1 is a more refined but less adaptable NK cell receptor than KIR2DL3Hugo G Hilton, Luca Vago, Anastazia M Older Aguilar, et al.
The Journal of Experimental Medicine|October 28, 2009
KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A*11 while diminishing avidity for HLA-CThorsten Graef, Achim K Moesta, Paul J Norman, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
The Annals of Thoracic Surgery|April 1, 1989
Predonated autologous blood use in elective cardiac surgeryL W Britton, D T Eastlund, S W Dziuban, et al.
The Journal of Thoracic and Cardiovascular Surgery|April 1, 1981
Four-year follow-up on the Albany experience with intrapleural BCG in lung cancerM F McKneally, C Maver, L Lininger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 10, 2012
Mutation at positively selected positions in the binding site for HLA-C shows that KIR2DL1 is a more refined but less adaptable NK cell receptor than KIR2DL3Hugo G Hilton, Luca Vago, Anastazia M Older Aguilar, et al.
The Journal of Experimental Medicine|October 28, 2009
KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A*11 while diminishing avidity for HLA-CThorsten Graef, Achim K Moesta, Paul J Norman, et al.
Pageof 2